Wall Street Journal. Europe 2000 Gardiner Harris - Abstracts
| Wall Street Journal. Europe 2000 Gardiner Harris | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| How Merck beat rivals from the new economy.(Online pharmaceuticals)(Statistical Data Included) | Business, international | Gardiner Harris | |||
| Merck appoints chief of research and development. | Business, international | Gardiner Harris | |||
| Merck reports strong profit, beats expectations. | Business, international | Gardiner Harris | |||
| Newest ulcer drug from AstraZeneca has a slight edge.(New Nexium drug slightly better than the older version.)(Brief Article)(Statistical Data Included) | Business, international | Stephen D. Moore, Gardiner Harris | |||
| Pfizer's earnings beat street's forecast. | Business, international | Gardiner Harris | |||
| Schering-Plough and Merck plan to jointly develop some medicines. | Business, international | Gardiner Harris | |||
| Schien explores selling company, warns of charge. | Business, international | Gardiner Harris | |||
| Warner-Lambert accepts Pfizer offer. | Business, international | Gardiner Harris, Nikhil Deogun, Robert Langreth | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.